Xin Liu

7PUBLICATIONS
14CO-AUTHORS
Molecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 27, 2026
Igniting antitumour immunity with cancer cell pyroptosis.

|Aug 18, 2025
A pair of congenic mice for imaging of transplants by positron emission tomography using anti-transferrin receptor nanobodies.

Thomas Balligand, Claire Carpenet, Sergi Olivé Palau

|Jul 16, 2025
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy.

Xin Liu, Camille Le Gall, Ryan K Alexander

|Jun 23, 2023
An armed anti-immunoglobulin light chain nanobody protects mice against influenza A and B infections.

Xin Liu, Thomas Balligand, Claire Carpenet

|Feb 09, 2022
Targeted Rejuvenation of Exhausted Chimeric Antigen Receptor T Cells Regresses Refractory Solid Tumors.

Qian Luo, John V Napoleon, Xin Liu

|Jun 23, 2021
Design of Neuraminidase-Targeted Imaging and Therapeutic Agents for the Diagnosis and Treatment of Influenza Virus Infections.

Xin Liu, Weichuan Luo, Boning Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Philip S Low

2 joint publications

Thomas Balligand

2 joint publications

Claire Carpenet

2 joint publications

Hidde L Ploegh